Polymorphism in Xeroderma Pigmentosum Complementation Group C Codon 939 and Aflatoxin B1-Related Hepatocellular Carcinoma in the Guangxi Population

被引:56
|
作者
Long, Xi-Dai [1 ,2 ]
Ma, Yun [3 ]
Zhou, Yuan-Feng [2 ]
Ma, Ai-Min [2 ]
Fu, Guo-Hui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Shanghai 200025, Peoples R China
[2] Youjiang Med Coll Nationalities, Dept Pathol, Baise, Peoples R China
[3] Guangxi Med Univ, Dept Pathol, Nanning, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
NUCLEOTIDE-EXCISION-REPAIR; DNA-REPAIR; BREAST-CANCER; XPC POLYMORPHISMS; DAMAGE RECOGNITION; GENE POLYMORPHISMS; LUNG-CANCER; RISK; CHINA; P53;
D O I
10.1002/hep.23807
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Genetic polymorphisms in DNA repair genes may influence individual variations in DNA repair capacity, and this may be associated with the risk and outcome of hepatocellular carcinoma (HCC) related to aflatoxin B1 (AFB1) exposure. In this study, we focused on the polymorphism of xeroderma pigmentosum complementation group C (XPC) codon 939 (rs#2228001), which is involved in nucleotide excision repair. We conducted a case-control study including 1156 HCC cases and 1402 controls without any evidence of hepatic disease to evaluate the associations between this polymorphism and HCC risk and prognosis in the Guangxi population. AFB1 DNA adduct levels, XPC genotypes, and XPC protein levels were tested with a comparative enzyme-linked immunosorbent assay, Taq-Man polymerase chain reaction for XPC genotypes, and immunohistochemistry, respectively. Higher AFB1 exposure was observed among HCC patients versus the control group [odds ratio (OR) = 9.88 for AFB1 exposure years and OR = 6.58 for AFB1 exposure levels]. The XPC codon 939 Gln alleles significantly increased HCC risk [OR = 1.25 (95% confidence interval = 1.03-1.52) for heterozygotes of the XPC codon 939 Lys and Gln alleles (XPC-LG) and OR = 1.81 (95% confidence interval = 1.36-2.40) for homozygotes of the XPC codon 939 Gln alleles (XPC-GG)]. Significant interactive effects between genotypes and AFB1 exposure status were also observed in the joint-effects analysis. This polymorphism, moreover, was correlated with XPC expression levels in cancerous tissues (r = 0.369, P < 0.001) and with the overall survival of HCC patients (the median survival times were 30, 25, and 19 months for patients with homozygotes of the XPC codon 939 Lys alleles, XPC-LG, and XPC-GG, respectively), especially under high AFB1 exposure conditions. Like AFB1 exposure, the XPC codon 939 polymorphism was an independent prognostic factor influencing the survival of HCC. Additionally, this polymorphism multiplicatively interacted with the xeroderma pigmentosum complementation group D codon 751 polymorphism with respect to HCC risk (ORinteraction = 1.71). Conclusion: These results suggest that the XPC codon 939 polymorphism may be associated with the risk and outcome of AFB1-related HCC in the Guangxi population and may interact with AFB1 exposure in the process of HCC induction by AFB1. (HEPATOLOGY 2010;52:13011309)
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 50 条
  • [1] Xeroderma pigmentosum Complementation group C Codon 939 polymorphism in association with Aflatoxin B1 exposure in Chronic Hepatitis (B & C) and Hepatocellular carcinoma in the Assamese population
    Parween, Wasifa
    Das, Anup Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 149 - 149
  • [2] Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma
    Long, Xi-Dai
    Huang, Xiao-Ying
    Yao, Jin-Guang
    Liao, Pinhu
    Tang, Yu-Jin
    Ma, Yun
    Xia, Qiang
    MOLECULAR CARCINOGENESIS, 2016, 55 (06) : 1060 - 1072
  • [3] Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans
    McGlynn, KA
    Hunter, K
    LeVoyer, T
    Roush, J
    Wise, P
    Michielli, RA
    Shen, FM
    Evans, AA
    London, WT
    Buetow, KH
    CANCER RESEARCH, 2003, 63 (15) : 4594 - 4601
  • [4] The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China
    Long, Xi Dai
    Ma, Yun
    Wei, Yi Ping
    Deng, Zhou Lin
    HEPATOLOGY RESEARCH, 2006, 36 (01) : 48 - 55
  • [5] Xeroderma Pigmentosum Complementation Group C Protein (XPC) Expression in Basal Cell Carcinoma
    Yang, Lien-Chuan
    Hsiao, Yu-Ping
    Lu, Chun-Te
    Huang, Chun-Huang
    Chao, Wan-Ru
    Lin, Yu-Ting
    Su, Hsuan-An
    Chang, Shih-Liang
    Chung, Jing-Gung
    IN VIVO, 2015, 29 (01): : 35 - 38
  • [6] MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis
    Liu, Yi-Xiao
    Long, Xi-Dai
    Xi, Zhi-Feng
    Ma, Yun
    Huang, Xiao-Ying
    Yao, Jin-Guang
    Wang, Chao
    Xing, Tian-Yu
    Xia, Qiang
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1-Related Hepatocellular Carcinoma
    Huang, Xiao-Ying
    Yao, Jin-Guang
    Huang, Bing-Chen
    Ma, Yun
    Xia, Qiang
    Long, Xi-Dai
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (02) : 334 - 343
  • [8] The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China
    Long, Xi Dai
    Ma, Yun
    Qu, De Ying
    Liu, Yun Guang
    Huang, Zhao Quan
    Huang, Yong Zhi
    Lin, Zhong Hui
    Wei, Ni Bo
    Zhou, Shu Chun
    ANNALS OF EPIDEMIOLOGY, 2008, 18 (07) : 572 - 578
  • [9] Polymorphisms in the Coding Region of X-Ray Repair Complementing Group 4 and Aflatoxin B1-Related Hepatocellular Carcinoma
    Long, Xi-Dai
    Yao, Jin-Guang
    Zeng, Zhi
    Ma, Yun
    Huang, Xiao-Ying
    Wei, Zhong-Hua
    Liu, Min
    Zhang, Jian-Jun
    Xue, Feng
    Zhai, Bo
    Xia, Qiang
    HEPATOLOGY, 2013, 58 (01) : 171 - 181
  • [10] Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice
    Liu, Shih-Ping
    Li, Ying-Shiuan
    Lee, Cheng-Ming
    Yen, Chia-Hung
    Liao, Yi-Jen
    Huang, Shiu-Feng
    Chien, Chau-Heng
    Chen, Yi-Ming Arthur
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 511 - 523